Cargando…
Safety and immunogenicity of a randomized phase I prime-boost trial with ALVAC-HIV (vCP205) and gp160 MN/LAI-2 adjuvanted in alum or polyphosphazene
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441772/ http://dx.doi.org/10.1186/1742-4690-9-S2-O50 |
| _version_ | 1782243371688919040 |
|---|---|
| author | O'Connell, RJ Polonis, VR Ratto-Kim, S Cox, J Jagodzinski, LL Malia, J Michael, NL Excler, J Robb, ML Kim, JH |
| author_facet | O'Connell, RJ Polonis, VR Ratto-Kim, S Cox, J Jagodzinski, LL Malia, J Michael, NL Excler, J Robb, ML Kim, JH |
| author_sort | O'Connell, RJ |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3441772 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-34417722012-09-18 Safety and immunogenicity of a randomized phase I prime-boost trial with ALVAC-HIV (vCP205) and gp160 MN/LAI-2 adjuvanted in alum or polyphosphazene O'Connell, RJ Polonis, VR Ratto-Kim, S Cox, J Jagodzinski, LL Malia, J Michael, NL Excler, J Robb, ML Kim, JH Retrovirology Oral Presentation BioMed Central 2012-09-13 /pmc/articles/PMC3441772/ http://dx.doi.org/10.1186/1742-4690-9-S2-O50 Text en Copyright ©2012 O'Connell et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Oral Presentation O'Connell, RJ Polonis, VR Ratto-Kim, S Cox, J Jagodzinski, LL Malia, J Michael, NL Excler, J Robb, ML Kim, JH Safety and immunogenicity of a randomized phase I prime-boost trial with ALVAC-HIV (vCP205) and gp160 MN/LAI-2 adjuvanted in alum or polyphosphazene |
| title | Safety and immunogenicity of a randomized phase I prime-boost trial with ALVAC-HIV (vCP205) and gp160 MN/LAI-2 adjuvanted in alum or polyphosphazene |
| title_full | Safety and immunogenicity of a randomized phase I prime-boost trial with ALVAC-HIV (vCP205) and gp160 MN/LAI-2 adjuvanted in alum or polyphosphazene |
| title_fullStr | Safety and immunogenicity of a randomized phase I prime-boost trial with ALVAC-HIV (vCP205) and gp160 MN/LAI-2 adjuvanted in alum or polyphosphazene |
| title_full_unstemmed | Safety and immunogenicity of a randomized phase I prime-boost trial with ALVAC-HIV (vCP205) and gp160 MN/LAI-2 adjuvanted in alum or polyphosphazene |
| title_short | Safety and immunogenicity of a randomized phase I prime-boost trial with ALVAC-HIV (vCP205) and gp160 MN/LAI-2 adjuvanted in alum or polyphosphazene |
| title_sort | safety and immunogenicity of a randomized phase i prime-boost trial with alvac-hiv (vcp205) and gp160 mn/lai-2 adjuvanted in alum or polyphosphazene |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441772/ http://dx.doi.org/10.1186/1742-4690-9-S2-O50 |
| work_keys_str_mv | AT oconnellrj safetyandimmunogenicityofarandomizedphaseiprimeboosttrialwithalvachivvcp205andgp160mnlai2adjuvantedinalumorpolyphosphazene AT polonisvr safetyandimmunogenicityofarandomizedphaseiprimeboosttrialwithalvachivvcp205andgp160mnlai2adjuvantedinalumorpolyphosphazene AT rattokims safetyandimmunogenicityofarandomizedphaseiprimeboosttrialwithalvachivvcp205andgp160mnlai2adjuvantedinalumorpolyphosphazene AT coxj safetyandimmunogenicityofarandomizedphaseiprimeboosttrialwithalvachivvcp205andgp160mnlai2adjuvantedinalumorpolyphosphazene AT jagodzinskill safetyandimmunogenicityofarandomizedphaseiprimeboosttrialwithalvachivvcp205andgp160mnlai2adjuvantedinalumorpolyphosphazene AT maliaj safetyandimmunogenicityofarandomizedphaseiprimeboosttrialwithalvachivvcp205andgp160mnlai2adjuvantedinalumorpolyphosphazene AT michaelnl safetyandimmunogenicityofarandomizedphaseiprimeboosttrialwithalvachivvcp205andgp160mnlai2adjuvantedinalumorpolyphosphazene AT exclerj safetyandimmunogenicityofarandomizedphaseiprimeboosttrialwithalvachivvcp205andgp160mnlai2adjuvantedinalumorpolyphosphazene AT robbml safetyandimmunogenicityofarandomizedphaseiprimeboosttrialwithalvachivvcp205andgp160mnlai2adjuvantedinalumorpolyphosphazene AT kimjh safetyandimmunogenicityofarandomizedphaseiprimeboosttrialwithalvachivvcp205andgp160mnlai2adjuvantedinalumorpolyphosphazene |